Actively Recruiting
Effects of Lower Body EMS Training in Postmenopausal Women
Led by Seoul National University · Updated on 2026-02-04
39
Participants Needed
1
Research Sites
21 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study evaluates the effects of a 6-week lower body Electrical Muscle Stimulation (EMS) training program on body composition, muscle function, and arteriosclerosis markers in postmenopausal women. Menopause is associated with a rapid decline in estrogen, which increases the risk of sarcopenia (muscle loss) and arterial stiffness (cardiovascular disease). While resistance training is effective for these conditions, participation rates among postmenopausal women are often low. This study investigates whether applying EMS during lower body resistance exercises provides superior benefits compared to resistance training alone or no intervention. Participants will be randomized into three groups: 1. Lower-body EMS combined with Resistance Training Group 2. Resistance Training Only Group 3. Control Group (No intervention) The study aims to verify the efficacy of EMS as a time-efficient and effective alternative exercise modality for improving vascular and musculoskeletal health in this population.
CONDITIONS
Official Title
Effects of Lower Body EMS Training in Postmenopausal Women
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Post-menopausal women (no menstruation for at least 12 months)
- Aged between 50 and 70 years
- Sedentary lifestyle with no regular resistance training in the last 6 months
- Able to perform lower body resistance exercises using the EMS suit
- Willing to participate and provide informed consent
You will not qualify if you...
- Presence of implanted electrical devices like pacemakers or defibrillators
- Severe bleeding disorders such as hemophilia
- Abdominal or inguinal hernia
- History of surgery, including stent insertion, within the last 6 months
- Severe cardiovascular diseases including myocardial infarction, heart failure, or arrhythmia
- Severe renal, neurological (including epilepsy), or oncological diseases currently under treatment
- Uncontrolled hypertension or severe arterial circulatory disorders
- Current use of hormone replacement therapy for menopause
- Use of medications for severe psychiatric disorders like depression or anxiety
- Acute infection or inflammation
- Influence of alcohol or drugs
- Any other condition deemed unsuitable by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Seoul National University
Seoul, Seoul, South Korea, 08826
Actively Recruiting
Research Team
K
Kyungho Kim, MS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here